No. of Pages: 172 | Report Code: BMIRE00025666 | Category: Life Sciences
南美脓毒症诊断市场预计将从2021年的3866万美元增长到2028年的6959万美元；预计2021年至2028年复合年增长率为8.8%。
感染是败血症的根本原因。脓毒症主要发生在免疫功能低下的人群中，例如接受化疗、接受脾切除手术、患有艾滋病和糖尿病等慢性疾病的人。在多种感染类型中，医院感染是住院患者发病和死亡的主要原因。因此，血液感染的增加将增加脓毒症诊断产品的采用。脓毒症具有很高的死亡率和发病率。根据美国国家生物技术信息中心 (NCBI) 2019 年 2 月发表的一篇文章，脓毒症死亡率约为 25-30%。此外，2020 年 9 月，世界卫生组织 (WHO) 估计，每年近 50% 的败血症病例发生在儿童中，导致 290 万人死亡。大多数死亡可以通过早期诊断和适当的临床管理来预防。这些死亡通常是腹泻病或下呼吸道感染的结果。因此，脓毒症的高发病率预计将增加对脓毒症诊断产品的需求，从而支持预测期内脓毒症诊断市场的增长。
随着新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动南美脓毒症诊断市场的发展。南美脓毒症诊断市场预计在预测期内将以良好的复合年增长率增长。
南美脓毒症诊断市场收入和预测至 2028 年（百万美元）
)
< strong>南美败血症诊断市场细分
南美脓毒症诊断市场根据产品、技术、方法、测试类型、病原体、最终用户和国家进行细分。根据产品，市场分为仪器、试剂和分析、血液培养基和软件。 2021年，血液培养基领域主导了南美脓毒症诊断市场。就技术而言，该市场分为分子诊断、流式细胞术、微流控、免疫分析、生物标志物和微生物学。 2021年，微生物学领域在南美脓毒症诊断市场中占据主导地位。根据方法，南美脓毒症诊断市场分为自动诊断和传统诊断。传统诊断细分市场在 2021 年占据主导地位。根据测试类型，南美脓毒症诊断市场分为即时检测和实验室测试。实验室检测领域在2021年占据市场主导地位。就病原体而言，南美脓毒症诊断市场分为细菌性脓毒症、真菌性脓毒症等。细菌性败血症细分市场在 2021 年占据主导地位。根据最终用户，南美败血症诊断市场分为医院、病理和参考实验室等。医院细分市场在 2021 年占据主导地位。根据国家/地区，南美洲脓毒症诊断市场分为巴西、阿根廷和南美洲其他地区。 2021 年，巴西在南美脓毒症诊断市场占据主导地位。
南美脓毒症诊断市场的主要参与者包括 Abbott； F. 霍夫曼拉罗什有限公司；免疫表达公司； BD；丹纳赫（贝克曼库尔特）； Luminex 公司；赛默飞世尔科技有限公司；生物梅里埃公司；和 Altair 的 T2 Biosystems, Inc.。
Strategic insights for South America Sepsis Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 38.66 Million |
| Market Size by 2028 | US$ 69.59 Million |
| Global CAGR (2021 - 2028) | 8.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South America Sepsis Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South America Sepsis Diagnostics Market is valued at US$ 38.66 Million in 2021, it is projected to reach US$ 69.59 Million by 2028.
As per our report South America Sepsis Diagnostics Market, the market size is valued at US$ 38.66 Million in 2021, projecting it to reach US$ 69.59 Million by 2028. This translates to a CAGR of approximately 8.8% during the forecast period.
The South America Sepsis Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Sepsis Diagnostics Market report:
The South America Sepsis Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Sepsis Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Sepsis Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Sepsis Diagnostics Market
